Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.220
-0.055 (-2.42%)
At close: Dec 5, 2025, 4:00 PM EST
2.240
+0.020 (0.90%)
After-hours: Dec 5, 2025, 7:30 PM EST
Neumora Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$8.00
Upside
+260.36%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold → Buy Upgrades $4 → $7 | Hold → Buy | Upgrades | $4 → $7 | +215.32% | Dec 1, 2025 |
| Stifel | Stifel | Hold Maintains $2 → $3 | Hold | Maintains | $2 → $3 | +35.14% | Nov 17, 2025 |
| Needham | Needham | Strong Buy Maintains $6 → $8 | Strong Buy | Maintains | $6 → $8 | +260.36% | Oct 28, 2025 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +530.63% | Oct 27, 2025 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Sep 16, 2025 |
| Mizuho | Mizuho | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +125.23% | Jul 16, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +125.23% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +125.23% | Apr 10, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Sell Downgrades $7 → $1 | Strong Buy → Sell | Downgrades | $7 → $1 | -54.95% | Apr 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 10, 2025 |
| Stifel | Stifel | Strong Buy → Hold Downgrades $6 → $2 | Strong Buy → Hold | Downgrades | $6 → $2 | -9.91% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +710.81% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | +80.18% | Mar 4, 2025 |
| Needham | Needham | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +125.23% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $18 | Strong Buy | Maintains | $30 → $18 | +710.81% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +1,251.35% | Feb 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.